Clinical trial
Immunogenicity and Safety Evaluation of Different Sequential Immunization Strategies by Sabin IPV and bOPV in Chinese Infants
NCT03147560 is registered in ClinicalTrials.gov with Zhejiang Provincial Center for Disease Control and Prevention as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immunogenicity and Safety Evaluation of Different Sequential Immunization Strategies by Sabin IPV and bOPV in Chinese Infants
- Lead sponsor
- Zhejiang Provincial Center for Disease Control and Prevention
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 2, 2017
- Completion date
- December 30, 2017
- Enrollment
- 528 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
polio